PRINTER'S NO. 1813
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
171
Session of
2023
INTRODUCED BY FLEMING, FLOOD, MADDEN, VENKAT, KINSEY, NEILSON,
KHAN, HILL-EVANS, GALLAGHER, SCHLOSSBERG, CURRY, HADDOCK,
PICKETT, SANCHEZ AND GREEN, JUNE 30, 2023
REFERRED TO COMMITTEE ON HEALTH, JUNE 30, 2023
A RESOLUTION
Designating the month of June 2023 as "Atherosclerotic
Cardiovascular Disease Month" in Pennsylvania.
WHEREAS, Cardiovascular disease is a leading cause of death
in the United States; and
WHEREAS, In the United States, approximately 24 million
patients have been diagnosed with atherosclerotic cardiovascular
disease (ASCVD) and are at risk of a detrimental cardiovascular
event; and
WHEREAS, ASCVD is linked to the build-up of cholesterol in
the arteries and the risk of detrimental cardiovascular events
can be modified by lowering low-density lipoprotein cholesterol
(LDL-C); and
WHEREAS, In 2016, nearly 70 million United States adults had
higher than recommended LDL-C levels; and
WHEREAS, Forty-seven million people in the United States
could benefit from treatment with lipid-lowering therapies to
manage cardiovascular risks; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
WHEREAS, Only 20% of people with ASCVD who are taking
statins, one of the leading lipid-lowering therapies, actually
achieve healthy levels of LDL-C; and
WHEREAS, The total direct and indirect cost of cardiovascular
diseases in the United States was $576 billion in 2015 and is
projected to climb to $1.1 trillion by 2035; and
WHEREAS, In this Commonwealth, 31% of adults have been told
by a health professional that they had a heart attack, stroke,
angina or coronary heart disease, which are some of the
manifestations of ASCVD; and
WHEREAS, In this Commonwealth, 18,341 people had ASCVD as an
underlying cause of death; therefore be it
RESOLVED, That the House of Representatives of the
Commonwealth of Pennsylvania designate June 2023 as
"Atherosclerotic Cardiovascular Disease Month" in Pennsylvania;
and be it further
RESOLVED, That the House of Representatives of the
Commonwealth of Pennsylvania urge State agencies to expand
comprehensive cardiovascular screening programs to allow for
earlier identification of patients at risk of cardiovascular
events; and be it further
RESOLVED, That the House of Representatives of the
Commonwealth of Pennsylvania urge State agencies to explore ways
to collaborate with Federal and national agencies and
organizations to establish and expand comprehensive
cardiovascular screening programs; and be it further
RESOLVED, That the House of Representatives of the
Commonwealth of Pennsylvania urge an update of the
Commonwealth's cardiovascular plan to accelerate quality
improvements in the care rendered to patients to ensure
20230HR0171PN1813 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
screening, treatment, monitoring and improved health outcomes
are achieved; and be it further
RESOLVED, That the House of Representatives of the
Commonwealth of Pennsylvania support the creation of policies to
decrease the rising number of deaths of Americans as a result of
ASCVD; and be it further
RESOLVED, That a copy of this resolution be transmitted to
the President of the United States, the Vice President of the
United States, the members of each House of Congress, the
Governor, the members of the Senate of Pennsylvania and other
Federal and State officials and agencies as appropriate.
20230HR0171PN1813 - 3 -
1
2
3
4
5
6
7
8
9
10
11